Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease

Inflamm Bowel Dis. 2009 Oct;15(10):1449-51. doi: 10.1002/ibd.20823.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Azathioprine / adverse effects*
  • Crohn Disease / drug therapy*
  • Drug Therapy, Combination
  • Epstein-Barr Virus Infections / chemically induced*
  • Epstein-Barr Virus Infections / drug therapy
  • Epstein-Barr Virus Infections / virology
  • Etoposide / therapeutic use
  • Female
  • Glucocorticoids / therapeutic use
  • Herpesvirus 4, Human / isolation & purification*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Lymphohistiocytosis, Hemophagocytic / chemically induced*
  • Lymphohistiocytosis, Hemophagocytic / drug therapy
  • Lymphohistiocytosis, Hemophagocytic / virology
  • Lymphoproliferative Disorders / chemically induced*
  • Lymphoproliferative Disorders / drug therapy
  • Lymphoproliferative Disorders / virology
  • Middle Aged
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Glucocorticoids
  • Immunosuppressive Agents
  • Rituximab
  • Etoposide
  • Azathioprine